BackAdaptive Biotechnologies Overview
Adaptive Biotechnologies Corp

Adaptive Biotechnologies Target Price

Where could ADPT trade next? Consensus target price: $24.

Get informed when a big investor buys or sells

+ Follow

Share Price

$25.25

Average Target Price

$23.905.3% downside

5 analysts in the last 4 months

High: $27.5 | Low: $20

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-04Piper Sandler$27.58.9% upsideOpen
2026-07-30Guggenheim$251% downsideOpen
2026-07-30BTIGMark Massaro$251% downsideOpen
2026-07-09Morgan Stanley$2020.8% downsideOpen
2026-06-29Guggenheim$2212.9% downsideOpen
2026-02-06BTIG$2212.9% downsideOpen
2026-02-06Piper SandlerSebastian Sandler$2116.8% downsideOpen
2026-01-26Guggenheim$2116.8% downsideOpen
2025-12-01Morgan StanleyKallum Titchmarsh$2116.8% downsideOpen
2025-10-15Piper Sandler$2020.8% downsideOpen
2025-09-30Guggenheim$2020.8% downsideOpen
2024-04-04BTIGMark Massaro$580.2% downsideOpen
2022-12-21Piper SandlerDavid Westenberg$1444.6% downsideOpen
2022-08-17Piper SandlerDavid Westenberg$1252.5% downsideOpen
2022-06-13Piper SandlerDavid Westenberg$7.570.3% downsideOpen
2022-05-06Morgan Stanley$1828.7% downsideOpen

Adaptive Biotechnologies (ADPT) FAQ

As of the most recent data, ADPT shows a target price of $24. Scroll down for historical charts and peer comparison views.

If Adaptive Biotechnologies moved to the average analyst target of $24, shares would be roughly 5.3% lower than $25.25. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Adaptive Biotechnologies's earnings trajectory.

Besides this target price page, Stockcircle has Adaptive Biotechnologies's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $24) with ownership activity and broader fundamentals.

Adaptive Biotechnologies's target price is $24; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.